ACADIA PHARMACEUTICALS INC

ACAD · Nasdaq · SIC 2834: Pharmaceutical Preparations
274
SEC Filings

Business Summary

. 3 Item 1A. Risk Factors . 26 Item 1B. Unresolved Staff Comments. 64 Item 1C. Cybersecurity. 64 Item 2. Properties . 66 Item 3. Legal Proceedings . 66 Item 4. Mine Safety Disclosures . 67 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. 68 Item 6. [Reserved] 69 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations. 69 Item 7A. Quantitative and Qualitative Disclosures About Market R...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionACADdiscussed_in_filing Cybersecurity
topic_mentionACADdiscussed_in_filing Cybersecurity
topic_mentionACADdiscussed_in_filing Cybersecurity
topic_mentionACADdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-072519EDGAR88K words
2025-02-272024-12-310000950170-25-029253EDGAR—
2024-02-282023-12-310000950170-24-021473EDGAR—
2023-02-282022-12-310000950170-23-004757EDGAR—
2022-03-012021-12-310000950170-22-002392EDGAR—
2021-02-252020-12-310001564590-21-008372EDGAR—
2020-02-272019-12-310001564590-20-006889EDGAR—
2019-02-272018-12-310001564590-19-004596EDGAR—
2018-02-272017-12-310001564590-18-003526EDGAR—
2017-02-282016-12-310001564590-17-002866EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-267453EDGAR49K words
2025-08-072025-06-300000950170-25-104295EDGAR—
2025-05-082025-03-310000950170-25-066231EDGAR—
2024-11-072024-09-300000950170-24-122513EDGAR—
2024-08-072024-06-300000950170-24-092163EDGAR—
2024-05-092024-03-310000950170-24-056077EDGAR—
2023-11-032023-09-300000950170-23-058436EDGAR—
2023-08-032023-06-300000950170-23-037458EDGAR—
2023-05-082023-03-310000950170-23-018927EDGAR—
2022-11-032022-09-300000950170-22-021438EDGAR—
2022-08-092022-06-300000950170-22-015642EDGAR—
2022-05-052022-03-310000950170-22-007468EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001193125-26-092213EDGAR1K words
2026-02-250001193125-26-071674EDGAR—
2026-01-130001193125-26-011706EDGAR—
2025-11-050001193125-25-266959EDGAR—
2025-11-030001193125-25-262610EDGAR—
2025-08-060000950170-25-104092EDGAR—
2025-06-100001193125-25-138452EDGAR—
2025-05-290001193125-25-130620EDGAR—
2025-05-200001193125-25-123175EDGAR—
2025-05-070000950170-25-065672EDGAR—

274 total filings indexed. 242 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC. AEON — AEON Biopharma, Inc.

Company Identity

CIK0001070494
TickerACAD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e41a524585ce08c28c7c073003712baff54356b0a6645b265aa18dd1d2788bbf
parent: 4d09c2e93300474303f2a5003ed606e33bddc1bbaabe7df59b528cfb6c0ca8f9
content hash: ea7a724005f9f594552c4e736503d1051853eaaf4a2799ff916d491febd78a08
signed: 2026-04-13T04:43:25.806Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf